Foluso Olabisi Ademuyiwa, MD, MPH, MSCI

Medical Oncologist

Foluso Olabisi Ademuyiwa

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Clinical Expertise

  • Breast Cancer

  • Medical Oncology

Primary Academic Title

Professor of Medicine, Division of Oncology, WashU Medicine

Board Certification

  • 2006: American Board of Internal Medicine, Internal Medicine
  • 2009: American Board of Internal Medicine, Medical Oncology

Training

  • 1999 - 2000: Intern, University College Hospital, Ibadan, Nigeria
  • 2002 - 2006: Resident and Chief Resident, Medicine and Pediatrics, Bridgeport Hospital/Yale New Haven Health, Bridgeport, CT
  • 2006 - 2009: Fellow, Hematology/Oncology, Indiana University, IN

Education

  • 1999: MD, University of Ibadan, Ibadan, Nigeria
  • 2001: MPH, Johns Hopkins University, Baltimore, MD
  • 2016: MSCI, WashU Medicine, St. Louis, MO

Research & Selected Publications

Research Interest

Breast cancer clinical trials, triple negative breast cancer, early-onset breast cancer, racial disparities.

Research Publications

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial
Authors:

Kong T, Mabry A, Highkin M, one or more additional authors omitted Ademuyiwa F, one or more additional authors omitted Ma CX

Journal & Year:

Nat Commun | 2026

Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer
Authors:

Ademuyiwa FO, Ma CX, Weilbaecher K, one or more additional authors omitted Davis A

Journal & Year:

Clin Cancer Res | 2025

Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
Authors:

Iglesia MD, Jayasinghe RG, Chen S, one or more additional authors omitted Ademuyiwa F, one or more additional authors omitted Ding L

Journal & Year:

Nat Cancer | 2024

Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
Authors:

Hensing WL, Gerratana L, Clifton K, one or more additional authors omitted Ademuyiwa FO, one or more additional authors omitted Davis AA

Journal & Year:

Clin Cancer Res | 2023